Bangladesh — Fishery/Seafood Products

← back to leaderboard

Bangladesh received 23 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 7 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are salmonella, vetdrugres, and nitrofuran. No trade baseline is published for this commodity from Bangladesh, so no per-$1B rate is shown here.

Of these, 22 were hazard refusals and 1 were paperwork refusals.

Exporting from Bangladesh? Get an email when shipments from Bangladesh are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q4 2023-Q4: 0 5 2024-Q1 2024-Q1: 5 3 2024-Q2 2024-Q2: 3 1 2024-Q3 2024-Q3: 1 0 2024-Q4 2024-Q4: 0 1 2025-Q1 2025-Q1: 1 1 2025-Q2 2025-Q2: 1 0 2025-Q3 2025-Q3: 0 1 2025-Q4 2025-Q4: 1 2 2026-Q1 2026-Q1: 2 7 2026-Q2 2026-Q2: 7 2 2026-Q3 2026-Q3: 2

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Fish-Other 14 salmonella
Shrimp-Prawn 9 vetdrugres

Recent rejections